Insulin resistance persists despite a metabolically healthy obesity phenotype.
Kristin K HoddyChristopher L AxelrodJacob T MeyAdithya HariRobbie A BeylJourdan B BlairWagner S DantasJohn P KirwanPublished in: Obesity (Silver Spring, Md.) (2021)
Participants with MHO had distinct clinical measures related to hypertension, lipid metabolism, and glycemic control compared with a healthy reference group. Peripheral insulin resistance in obesity independent of metabolic status portends increased risk for type 2 diabetes in the MHO patient population.